CHICAGO -- An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and ...

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.

The ELEVATUM study's initial data showed vision improvements in patients who were given Vabysmo every eight weeks for a year.

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

Christine N. Kay, MD, discussed her presentation, "Deuterated vitamin A preserves vision in Stargardt’s disease (TEASE study) ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...